The rating assignment is based on a number of factors, including UMMS’ solid market share and strong position as the clinical training venue for Baltimore-based University of Maryland School of Medicine.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that UMMS will continue to generate stable margins.
More articles on healthcare finance:
ACA repeal would trigger $166B loss for hospitals by 2026 — 3 things to know from AHA, FAH
6 experts share healthcare RCM predictions for 2017
Fitch issues stable outlook for US healthcare
